Feasibility of Systematic Domestic Violence Screening Using WAST in the Villefranche/Saône Emergency Department.

NCT07827534 | Completed

• 2 other identifiers: HNO25_0012025-A00252-47
• Study Type: observational
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

This single-center observational study aims to assess the feasibility of systematically screening for intimate partner violence (IPV) against women in the emergency department of Hôpital Nord-Ouest de Villefranche-sur-Saône. The study utilizes the Woman Abuse Screening Tool (WAST), a self-administered questionnaire, to identify cases of IPV. The primary objective is to evaluate the feasibility and acceptability of implementing this systematic screening within an emergency setting. The study will measure feasibility through factors such as the implementation rate and adherence by healthcare staff, while acceptability will be assessed based on patient participation and response rates. By analyzing these criteria, the study seeks to determine whether IPV screening can be effectively integrated into routine emergency care. The findings are expected to provide insights into potential barriers and facilitators for screening implementation, contributing to improved detection and support strategies for women experiencing domestic violence.

Conditions

Violence Against Women (VAW)

Keywords

Patient Acceptability; Woman Abuse Screening Tool (WAST); Screening Feasibility; Intimate Partner Violence (IPV); Violence Against Women (VAW)

Outcome Measures

Primary Outcomes (2)

• Feasibility of systematic screening using WAST

  Assessed by the proportion of eligible women screened with WAST.

  At the time of outpatient consultation (Day 0)

• Acceptability of WAST

  Assessed using an acceptability questionnaire completed by healthcare patient

  At the time of outpatient consultation (Day 0)

Interventions

Self-questionnaire OTHER

Self-questionnaire completed in the waiting room of the emergency department, either on paper or online by scanning a QR-code

Eligibility Criteria

• Age: 18 Years+
• Sex: female
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Adult female patients presenting spontaneously to the Emergency Department of Villefranche-sur-Saône Hospital who meet all inclusion criteria and none of the exclusion criteria. The required sample size is estimated at 101 participants.

You may qualify if:

• Female
• Aged 18 years or older
• Able to read and write French

You may not qualify if:

• Refusal to participate in the study
• Neurocognitive disorders, confusion, or psychotic disorders that preclude study participation
• Severe uncorrected sensory impairment
• Life-threatening emergency requiring immediate management in the resuscitation area

Sponsors & Collaborators

• L'hôpital Nord-Ouest - Villefranche Villefranche sur Saône: lead

Study Sites (1)

Hopitaux Nord-Ouest

Gleizé, France, 69400, France

Location

Study Officials

• LUCIE TEYSSIER, GENERAL MEDECINE

  STUDY CHAIR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 5, 2025
• First Posted: September 18, 2026
• Study Start: April 7, 2025
• Primary Completion: June 1, 2025
• Study Completion: June 1, 2025
• Last Updated: September 18, 2026

Record last verified: 2026-09

Locations

FR (1)